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Infections by Chlamydia trachomatis are a leading cause of sexually transmitted disease, infertility, and blindness. Within the species, two biovars have been described which are responsible for human disease (19) . The trachoma biovar infects mucosal epithelial cells and produces localized infection of the urogenital tract and eyes. The lymphogranuloma venereum ( LGV) biovar has broader host cell specificity and causes more invasive sexually transmitted disease. Chlamydiae have a unique life cycle in which the bacteria alternate between two developmental forms, the extracellular elementary body (EB) and the intracellular reticulate body. Only the EB is capable of extracellular survival, host cell recognition, and invasion, suggesting a fundamental role for EB outer membrane constituents in infectivity.
The differences in infectivity observed between the trachoma and LGV biovars may be mediated by dissimilarity in outer membrane composition, variation in primary structure of the EB constituents, or higher-ordered structural heterogeneity. The EB outer membrane contains three cysteinerich proteins with molecular weights of about 40,000 (MOMP), 60,000 (OMP2), and 15,000. The chlamydial cell envelope lacks a peptidoglycan layer for structural integrity (2) . It has been proposed that in its absence inter-and intramolecular disulfide bonding among the cysteine-rich proteins imparts rigidity to the EB outer membrane (22) .
Complete sequence information for the MOMP-encoding genes of several serotypes (25, 26) indicates that this protein is antigenically complex, possessing species-, subspeciesand serovar-specific epitopes on each molecule (28) . The 15,000-molecular-weight cysteine-rich protein has recently been described as possessing both biovar-and speciesspecific epitopes (31) . To date, the epitopes identified on the 60,000-molecular-weight outer-membrane protein by monoclonal antibodies have all been species specific, demonstrating less antigenic diversity than the other cysteine-rich proteins (20) .
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Despite the evidence for a shared antigenic structure, there are several striking physical differences between the 60,000-molecular-weight proteins of the trachoma biovar and the more invasive LGV biovar. This protein appears as a predominant single band in gel electrophoresis of trachoma strains but is present as a less intense doublet in LGV strains (3) . Recently, peptide maps have demonstrated that there are significant structural differences between the proteins of these two biovars (20) . Further, it has been observed that the 60,000-molecular-weight protein of the trachoma biovar has a nearly neutral isoelectric point (pl), whereas the LGV proteins have a net positive charge, with a pl of 8.5 (15) , as has the Xgt11 bacteriophage recombinant from serovar L2 designated gtll/L2/46 (24) . Bacteriophage X1059, its host Escherichia coli Q359 (12) , and the pUC plasmids and M13 phage systems, have been previously described (18) .
Antiserum production. The ,-galactosidase fusion peptide from the induced lysogen of gtll/L2/46 was fractionated by bacterial cell lysis in 1% Zwittergent (Calbiochem-Behring), followed by centrifugation through 20% sucrose at 20,000 x g. A rabbit was immunized with about 20 ,g of the fractionated protein subcutaneously with Freund complete adjuvant. The rabbit was boosted intravenously with about 10 pig of the protein 14 and 21 days after the first immunization. Antiserum was collected 10 days after the last immunization.
Immunoblot analysis. EBs were harvested and Renografin (E. R. Squibb & Sons) purified as previously described (15) . Outer membranes were prepared by treatment of EBs with sarcosyl as described by Caldwell et al. (7) . Sarcosylinsoluble pellets were placed in sodium dodecyl sulfate sample buffer containing P-mercaptoethanol, loaded onto polyacrylamide gels, electrophoresed, transferred, and probed by standard methods (24) . The rabbit antiserum described above was used as the primary antibody at a dilution of 1/1,QOO, followed by horse radish peroxidaseconjugated goat anti-rabbit immunoglobulin G (Zymed Labs, Inc.). The chromogen 4-chloro-1-naphthol (Sigma Chemical Co.) was used to detect antibody binding as previously described (24) .
Characterization of gtll/L2/46 DNA. DNA was isolated from the recombinant bacteriophage as previously described (16) . The insert DNA was identified by digestion of bacteriophage DNA with EcoRI and separation on agarose gels. The location of the chlamydial DNA insert relative to lacZ was determined by restriction endonuclease analysis with SstI, KpnI, and EcoRI. An 870-bp EcoRI chlamydial insert from gtll/L2/46 was subcloned into pUC18 and designated J702. Standard methods were used for enzyme analysis and pUC cloning (16) .
Construction of genomic libraries for C. trachomatis serovar L2. DNA from C. trachomatis L2/434/Bu was isolated as previously described (24) . Standard procedures were used for enzymatic reactions and for isolation of phage DNA (16) . Chlamydial genomic DNA was partially digested with Sau3A. The Saq3A fragments were ligated to BamHI-digested X1059 DNA and packaged into phage by using commercially prepared extracts (Amersham Corp.). Recombinant phage were plated on Q359 for screening (12) . Selection and analysis of X1059 recombinant phage. The chlamydial insert DNA from J702 was purified by extraction from low-melting-point agarose and labeled with 32P. Labeling was performed by the random-primer method with commercially prepared reagents (Bethesda Research Laboratories, Inc.). Phage were plated in E. coli Q359 at densities of about 103 PFU/150-mm-diameter plate and screened with the 32P-labeled insert DNA as previously described (25) . Plaques that produced strong signals were picked and reassayed to ensure plaque purity. DNA was isolated from the positive clones as previously described (16) . Clones were digested with restriction endonucleases, and restriction fragments of interest were identified by Southern blot analysis (16) . SstI fragments of interest were subcloned into pUC18. Two pUC clones, R708 and R709, were mapped by restric- tion endonuclease analysis with SstI, PstI, XbaI, Sall, and BamHI.
DNA sequencing. DNA restriction endonuclease fragments to be sequenced were cloned into M13mpl8 and M13mpl9. The M13 clones were sequenced by the dideoxy-chain termination method by using commercially available reagents (Sequenase; United States Biochemical). When required, oligonucleotide probes were prepared in an automated synthesizer (Biosearch 8600) and used to continue sequencing. In addition, the Agtll EcoRI site forward primer (New England BioLabs) was used for sequencing of a fragment containing Xgtll DNA upstream of the EcoRI cloning site. All sequences were confirmed by sequencing of the complementary strand.
Protein sequencing. Outer membranes of chlamydial EBs were prepared by treatment with sarcosyl as described by Caldwell et al. (7) . Sarcosyl-insoluble pellets were placed in sodium dodecyl sulfate sample buffer containing P-mercaptoethanol, separated on 7.5% polyacrylamide gels, transferred to a membrane (Immobilon; Millipore Corp.), stained with Coomassie brilliant blue, and destained, and the bands were cut out with a razor blade as described by Matsudaira (17) . Samples were sent to the Louisiana State University Bio Technologies Unit for sequencing on a pulsed-liquid protein microsequencer (Applied Biosystems model 477A). Amino acid residues were determined from values in the 5-to 10-pmol range.
RESULTS
Characterization of gtll/L2/46. Antiserum to the recombinant bacteriophage gtll/L2/46 (24) was used to probe immunoblots of serovar L2 EB lysates. Two bands with relative mobilities of 56,000 and 58,000 were observed (Fig. 1 ). Upon fractionation, it was revealed that this antiserum reacted only with the outer membrane (sarcosyl insoluble) of chlamydial EBs. While two bands were observed with serovar L2, the antiserum reacted with only a single 57,000-molecular-weight species in trachoma serovars C and F ( Fig servar C is shown). The fusion peptide from gtll/L2/46 was reactive by immunoblot with one of three monoclonal antibodies that bind distinct epitopes on OMP2 (W. J. Newhall, personal communication). From these data, we concluded that the fusion peptide from this recombinant represents an antigenic portion of the 60,000-molecular-weight outer membrane protein described by several investigators (3, 10, 21) .
The fusion peptide had a molecular weight of about 146,000 by polyacrylamide gel electrophoresis, suggesting that the chlamydial DNA insert encodes for a polypeptide with a molecular weight of about 30,000. DNA prepared from gtll/L2/46 was mapped with KpnI, SstI, and EcoRI. An 870-bp EcoRI insert adjacent to lacZ was identified (Fig.  2) .
The 870-bp fragment was cloned into M13mp18 and M13mpl9 and sequenced. The sequence revealed only one significant open reading frame, which spanned the entire sequence. In addition, a 1.4-kilobase (kb) SstI fragment from gtll/L2/46 (Fig. 2) was cloned into M13mpl9. This fragment included a portion of the ,-galactosidase gene upstream of the cloning site in addition to the insert DNA. This allowed use of the Agtll forward primer, which hybridizes to lacZ 13 nucleotides upstream of the EcoRI cloning site. A sequence obtained from this clone confirmed that the 870-bp EcoRI fragment was adjacent to and in frame with lacZ. The molecular weight of the translated open reading frame was 30,416, consistent with that of the protein product. The sequence of this insert DNA is described below with the entire gene sequence.
Selection and analysis of genomic recombinants. The 870-bp chlamydial DNA insert from gtll/L2/46 was used to select recombinants from a X1059 genomic library of serovar L2. An SstI site had been identified within the gene for OMP2 by mapping of the gtll/L2/46 DNA. Thus, the DNA prepared from these X1059 recombinants was digested with SstI and evaluated by Southern hybridization. The presence of two bands (2.7 and 3.5 kb) which hybridized to the probe demonstrated that the X1059 clones contained the entire gene (data not shown). Both SstI fragments were subcloned into pUC18 and mapped (Fig. 2) . Restriction sites within the 870-bp fragment and within the two SstI fragments allowed orientation of the 3.5-kb fragment 5' to the 2.7-kb fragment.
Restriction endonuclease digests of C. trachomatis DNA obtained from serovar L2 were probed by Southern hybridization with the gtll/L2/46 chlamydial DNA insert. The probe hybridized to a single restriction fragment in XbaI, BamHI, and HindIlI digests while hybridizing to two bands in SstI digests (data not shown), indicating the presence of a single gene for OMP2. Southern hybridization was also performed on BamHI and HindlIl digests of DNA obtained from serovar I. Bands were detected which closely migrated with analogous bands from digests of LGV biovar DNA (Fig.  3 ). This shows that omp2 genes for trachoma and LGV biovars are in similar genomic contexts. Thus, gene differences which could account for the physical and structural differences observed in this protein are localized within a common gene framework.
Gene sequence. The sequencing strategy for omp2L2 is shown in Fig. 2 (27) . As with the ompi sequences (26) terminated by a single stop codon (TAA). Downstream (25 and the recently published DNA sequence for a putative C. bp) of the stop codon was a G+C-rich 10-bp dyad. This dyad trachomatis binding protein (13) , codon usage in this sehad the potential to form a stem-and-loop structure with a quence was strongly biased toward U or A in position 3. Amino acid sequence. The open reading frame of the omp2L2 gene was translated and, starting with the initial methionine, encoded 547 amino acids (Fig. 4) 54 ,533 (OMP2a) and 56,677 (OMP2,). The relative mobilities for OMP2 observed by polyacrylamide gel electrophoresis, 59,000 and 62,000 (10), may be artifactually high, since overestimation of mass is a common feature of gel electrophoresis systems. The first 17 amino-terminal residues of the trachoma serovar F mature OMP2 were determined by W. J. Newhall (personal communication) and are identical to the amino-terminal residues of serovar L2 OMP2a. Although a 40-amino-acid leader peptide is exceptionally long, both OMP2L2 signal sequence cleavage sites follow the -1, -3 rule described by von Heijne (29, 30) . In addition, the cleavage site resulting in OMP2 is the same at positions -1 and -3 (Leu-X-Ala) as that of the chlamydial MOMP leader peptide (25) , suggesting that OMP2 biovar differences are not due to the inability of trachoma strains to cleave at that site.
The amino acid composition of serovar L2 OMP2, as determined by translation of the open reading frame (Table  1) , included an excess of basic residues, consistent with the basic charge observed by isoelectric focusing techniques (3) . In addition, the two glutamic acid residues present in the 18 additional amino acids of OMP2,3 account for the slight isoelectric point difference observed between the OMP2 doublet bands. The translated open reading frame consisted of 24 cysteines (about 5%), which confirmed the cysteinerich nature of this protein as described by Hatch et al. (10) . Both the amino-terminal and carboxyl-terminal ends (within about 90 amino acids) were notably lacking in cysteine residues, and cysteine residues tend to be clustered in two regions within the protein (Fig. 5) . Of 24 cysteine residues, 15 were within four amino acid residues of a proline, and computer-assisted secondary structure evaluation (1) revealed that nearly every cysteine residue was immediately preceded by or fell within a beta turn (data not shown). This suggests that cysteine residues are near flexible peptide boundaries which may be important for disulfide-mediated membrane protein interactions. In general, OMP2 has a very even distribution of charged, polar, and hydrophobic residues, with two exceptions. The most notable is the positively charged, highly polar amino terminus (residues +3 to +25) (Fig. 5) . This 23-amino-acid stretch includes 11 charged residues (mostly lysines) and is uninterrupted by truly hydrophobic amino acids. There is one polar but not highly charged region of 18 amino acids (+369 to +411) within the polypeptide which overlaps the second cluster of cysteines. No significant stretches of hybrophobic amino acids were evident. DISCUSSION OMP2 of C. trachomatis functions as a key structural component of the unique chlamydial outer membrane which, in the absence of peptidoglycan, maintains rigidity via disulfide bonding of outer membrane proteins. Further, the cysteine-rich nature of this protein and its expression late in the developmental cycle suggest involvement in the disul- VOL. 171, 1989 fide-mediated changes that are essential for the switch between intracellular and extracellular stages of this organism (4, 9) . The antigenic significance of this protein in the host immune response is demonstrated by studies in which the presence of antibodies to OMP2 is consistently observed in active infection (5, 8, 21) and is correlated with disease status (5, 6, 11) . Although no differences in antigenicity have been observed between the OMP2s of trachoma and LGV biovars (3, 20) , significant differences in physical (20) and chemical (3) properties of this protein between biovars have been reported. The OMP2s of LGV and trachoma share important and conserved structural functions; thus, dissimilar properties could be related to the differences in infectivity observed between the two biovars.
EBs of the LGV biovar readily infect cell monolayers without the assistance of centrifugation or host cell pretreatment with polycations required by the trachoma biovar EBs. The OMP2 doublet of LGV biovar strains has been shown by Batteiger et al. (3) to have a pI of 8.5 to 9.0 as opposed to the nearly neutral pl of the trachoma biovar OMP2. They proposed that OMP2 may aid EB attachment to host cells by providing a local region of positive charge and that the difference in infectivity between biovars is due to the greater positive charge of the LGV OMP2 than that of the trachoma OMP2. Since the omp2 genes are highly conserved in genetic context between the biovars and the proteins are antigenically very similar, the biovar differences observed in OMP2s are probably localized to a defined domain(s) within the proteins. Protein sequencing of the serovar F (trachoma biovar) amino terminus (Newhall, personal communication) demonstrates that these differences are not localized to this charged region. Immunoblots with OMP2-specific antiserum show that trachoma OMP2 migrates midway in molecular weight between LGV OMP2,X and OMP2p, and yet the amino terminus of trachoma OMP2 is the same as that of LGV OMP2a. This suggests that trachoma OMP2 possesses a highly acidic region(s), absent in LGV strains, which accounts for both the molecular-weight and charge differences observed between these otherwise identical proteins. Trachoma gene differences may also account for the slight size difference observed in the BamHI restriction fragments by Southern analysis (Fig. 3) .
One of the distinctive features of the OMP2 of the LGV biovar strains is the presence of two antigenically identical bands which differ in molecular weight (3) . Southern analysis demonstrated that the two bands seen on protein gels were not derived from two genes. Protein sequencing of the two bands and analysis of the translated open reading frame revealed that the protein is cleaved at two alternate peptide cleavage sites, removing either a 22-amino-acid or a 40-amino-acid leader sequence. However, the existence of OMP2. in the outer membrane suggests that 22 (10) . Conservation of OMP2 polymorphism between species which exhibit similar culture infectivity characteristics but are otherwise highly divergent (19) (21) .
